Garg Pushkal
SEC CIK 1829252 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | EVP Chief R, D | 23.0K | — | $36.41M | 42 | 2022-08-03 | 2026-03-04 |
Most active insiders at ALNY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Greenstreet Yvonne | CEO, Dir | — | $24.46M |
| 2 | Fitzgerald Kevin Joseph | CSO, EVP, Head of Research | — | $10.74M |
| 3 | Garg Pushkal | EVP Chief R, D | — | $8.12M |
| 4 | Poulton Jeffrey V. | EVP, CFO | — | $4.95M |
| 5 | Tanguler Tolga | EVP, Chief Commercial Off | — | $3.06M |
| 6 | McLaughlin Melissa | CHRO | — | $1.27M |
| 7 | PYOTT DAVID E I | Dir | — | $1.15M |
| 8 | Reitan Colleen F | Dir | — | — |
| 9 | Sigal Charles Elliott | Dir | — | — |
| 10 | Arbuckle Stuart A | Dir | — | — |
Transactions 42
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-06 | 2026-03-04+ | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R, D | S - Sale | $323.53 | -4,713 | 23.0K | -17% | -$1.52M |
| DM | 2026-03-04 | 2026-03-02+ | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R, D | S - Sale | $323.63 | -3,492 | 26.5K | -12% | -$1.13M |
| D | 2026-03-04 | 2026-03-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R, D | A - Grant | $0.00 | +4,769 | 26.9K | +22% | $0 |
| D | 2026-03-02 | 2026-02-27 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R, D | M - OptEx | $0.00 | +1,908 | 26.8K | +8% | $0 |
| DM | 2026-03-02 | 2026-02-27 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R, D | S - Sale+OE | $331.34 | -4,627 | 22.1K | -17% | -$1.53M |
| 2026-02-17 | 2026-02-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R, D | A - Grant | $0.00 | +4,579 | 27.1K | +20% | $0 | |
| 2026-02-17 | 2026-02-13 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R, D | S - Sale | $310.08 | -2,242 | 24.8K | -8% | -$695.2K | |
| M | 2026-01-14 | 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R, D | S - Sale | $362.87 | -1,510 | 23.2K | -6% | -$547.9K |
| 2026-01-14 | 2026-01-11 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R, D | A - Grant | $0.00 | +3,800 | 24.0K | +19% | $0 | |
| M | 2025-10-03 | 2025-10-02+ | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R, D | S - Sale | $451.76 | -5,959 | 20.2K | -23% | -$2.69M |
| M | 2025-10-03 | 2025-10-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R, D | A - Grant | $0.00 | +5,959 | 26.2K | +29% | $0 |
| M | 2025-08-19 | 2025-08-18+ | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R, D | S - Sale | $455.89 | -2,851 | 21.4K | -12% | -$1.30M |
| 2025-08-19 | 2025-08-15 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R, D | A - Grant | $0.00 | +2,851 | 23.1K | +14% | $0 | |
| D | 2025-03-25 | 2025-03-24 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | M - OptEx | $42.22 | +5,445 | 25.7K | +27% | +$229.9K |
| DM | 2025-03-25 | 2025-03-21+ | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale+OE | $293.36 | -9,766 | 20.2K | -33% | -$2.86M |
| DM | 2025-03-05 | 2025-03-03+ | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale | $242.92 | -2,557 | 26.4K | -9% | -$621.2K |
| D | 2025-03-05 | 2025-03-03 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | A - Grant | $0.00 | +14.1K | 27.1K | +109% | $0 |
| DM | 2025-03-03 | 2025-02-28 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale+OE | $241.69 | -935 | 13.7K | -6% | -$226.0K |
| D | 2025-03-03 | 2025-02-27 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | M - OptEx | $0.00 | +1,908 | 13.9K | +16% | $0 |
| M | 2025-02-18 | 2025-02-14+ | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale | $253.43 | -3,109 | 12.4K | -20% | -$787.9K |
| 2025-02-18 | 2025-02-13 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | A - Grant | $0.00 | +3,109 | 15.1K | +26% | $0 | |
| DM | 2025-01-29 | 2025-01-27 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | M - OptEx | $88.95 | +48.9K | 39.6K | New | +$4.35M |
| D | 2025-01-29 | 2025-01-27 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale+OE | $285.00 | -52.6K | 12.0K | -81% | -$14.99M |
| M | 2024-12-13 | 2024-12-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale | $251.00 | -1,752 | 15.8K | -10% | -$439.8K |
| 2024-11-27 | 2024-11-25 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | A - Grant | $0.00 | +3,434 | 19.1K | +22% | $0 | |
| M | 2024-11-27 | 2024-11-26 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale | $250.98 | -1,682 | 17.5K | -9% | -$422.1K |
| 2024-10-10 | 2024-10-08 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | A - Grant | $0.00 | +96 | 15.7K | +0.6% | $0 | |
| M | 2024-06-26 | 2024-06-25 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale | $230.99 | -2,103 | 17.5K | -11% | -$485.8K |
| 2024-06-26 | 2024-06-24 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | A - Grant | $0.00 | +4,295 | 17.7K | +32% | $0 | |
| D | 2024-03-05 | 2024-03-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | A - Grant | $0.00 | +4,751 | 13.4K | +55% | $0 |
| DM | 2024-02-29 | 2024-02-28 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale+OE | $155.30 | -574 | 8,666 | -6% | -$89.1K |
| D | 2024-02-29 | 2024-02-27 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | M - OptEx | $0.00 | +1,908 | 9,240 | +26% | $0 |
| 2024-02-20 | 2024-02-15 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | A - Grant | $0.00 | +4,295 | 8,640 | +99% | $0 | |
| M | 2024-02-20 | 2024-02-16 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale | $148.06 | -1,308 | 8,160 | -14% | -$193.7K |
| M | 2023-08-07 | 2023-08-04+ | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale | $184.78 | -7,627 | 4,345 | -64% | -$1.41M |
| M | 2023-08-07 | 2023-08-03 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | A - Grant | $0.00 | +7,627 | 8,863 | +617% | $0 |
| M | 2023-04-28 | 2023-04-27+ | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale | $197.12 | -4,294 | 7,009 | -38% | -$846.4K |
| 2023-04-28 | 2023-04-26 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | A - Grant | $0.00 | +4,294 | 8,639 | +99% | $0 | |
| DM | 2023-03-07 | 2023-03-03 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | M - OptEx | $96.45 | +5,000 | 22.4K | +29% | +$482.2K |
| D | 2023-03-07 | 2023-03-03 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale+OE | $200.00 | -18.1K | 4,345 | -81% | -$3.61M |
| M | 2022-08-05 | 2022-08-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | F - Tax | $191.55 | -5,086 | 17.9K | -22% | -$974.2K |
| M | 2022-08-05 | 2022-08-03 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO, EVP Dev, Med Affairs | A - Grant | $0.00 | +11.3K | 15.7K | +257% | $0 |
Purchase Sale Sale after option exercise All abbreviations